Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Genetics

Can BWS Present as Isolated Lateralized Overgrowth?

At a Glance

Yes, a child can have Beckwith-Wiedemann syndrome even if their only symptom is one enlarged limb, a condition known as isolated lateralized overgrowth (ILO). Doctors recommend genetic testing and regular abdominal ultrasounds for these children to monitor for associated childhood tumors.

Yes, your child can have Beckwith-Wiedemann syndrome (BWS) even if their only symptom is that one arm or leg is larger than the other [1][2]. In the past, this single symptom was often referred to as isolated hemihyperplasia. Today, doctors call it isolated lateralized overgrowth (ILO), and it is officially recognized as part of the Beckwith-Wiedemann spectrum [2][3].

Because BWS is not a single, uniform condition but rather a spectrum of physical traits and genetic changes, children can experience very different symptoms. Some children have classic BWS with many features, while others only have one specific feature, like an enlarged limb [2][4].

The Beckwith-Wiedemann Spectrum (BWSp)

Medical experts now use the term Beckwith-Wiedemann spectrum (BWSp) to describe the wide variety of ways this condition can appear [2]. The spectrum includes:

  • Classic BWS: Children with multiple traditional features (such as a large tongue, abdominal wall defects, and overgrowth).
  • Atypical BWS: Children with fewer or less common features.
  • Isolated Lateralized Overgrowth (ILO): Children whose only noticeable physical difference is that one side of the body, or a specific limb, is larger than the other [3][5].

Even when lateralized overgrowth is the only symptom, it shares the same underlying genetic causes on chromosome 11 (specifically the 11p15.5 region) as the rest of the Beckwith-Wiedemann spectrum [4][1].

How the Clinical Scoring System Works

Doctors use a clinical scoring system to determine if a child should be tested for BWSp. In this system, symptoms are categorized as either “cardinal” (major) or “suggestive” (minor) features [6][2].

A cardinal feature is worth 2 points, and a score of 2 points is the threshold required to recommend genetic testing. Lateralized overgrowth is considered a cardinal feature [2][7]. This means that even if a child has no other symptoms, the presence of lateralized overgrowth alone scores exactly enough points to prompt doctors to recommend genetic testing [6][2].

The Role of Genetic Testing

If your child has an enlarged limb, genetic testing helps clarify whether the overgrowth is tied to the Beckwith-Wiedemann spectrum or another genetic condition.

  • Blood Testing: Doctors typically start with a blood test to look for changes in the 11p15.5 region of the DNA [5]. However, children with only isolated lateralized overgrowth often have these genetic changes in a “mosaic” pattern—meaning the genetic change is only present in certain cells (like the larger limb) and not in the blood [5][8].
  • Tissue Testing: Because of mosaicism, standard blood tests come back negative in 70% to 90% of children with ILO [3][9]. If the blood test is negative, doctors will often recommend testing cells from the affected area, usually through a small skin biopsy or cheek swab [5][10].
  • Other Conditions: Testing also helps rule out other syndromes that cause overgrowth, such as PIK3CA-related overgrowth spectrum (PROS), which requires different testing and monitoring [7][11].

Tumor Screening and Surveillance

While it can be scary to think about cancer, confirming your child’s diagnosis means you and your care team can proactively monitor their health. The main reason to confirm a BWSp diagnosis is to manage the risk of childhood tumors, particularly Wilms tumor (a kidney cancer) and hepatoblastoma (a liver cancer) [12][13].

Research shows that children with isolated lateralized overgrowth have a lower overall risk of developing these tumors (around 3.5%) compared to children with classic BWS (around 12.5%) [3]. However, this risk is still high enough that routine surveillance is strongly recommended [8][3].

Standard surveillance guidelines typically involve:

  • Abdominal Ultrasounds: Usually performed every 3 months until the child reaches age 7 or 8, when the risk of Wilms tumor drops significantly [10][3].
  • Alpha-fetoprotein (AFP) Blood Tests: Sometimes used to screen for hepatoblastoma every 3 months until around age 4, depending on the child’s specific genetic profile.

Even if genetic test results come back negative but the physical overgrowth remains, your medical team will likely still suggest this regular screening to ensure any potential issues are caught early [10][3].

Managing the Enlarged Limb

Beyond genetics and screening, the physical reality of an enlarged limb needs attention. You will likely be referred to a pediatric orthopedist or a physical therapist. They can help monitor your child’s growth and address any mobility differences. Depending on the degree of overgrowth, interventions might include shoe lifts to balance leg length or, in some cases, procedures to slow the growth of the longer limb as the child gets older.

Common questions in this guide

Does my child need genetic testing if their only symptom is an enlarged limb?
Yes. Having one larger limb, known as isolated lateralized overgrowth, scores enough points on the clinical scoring system to automatically recommend genetic testing for the Beckwith-Wiedemann spectrum.
Why might a blood test come back negative for BWS if my child has an enlarged leg?
Children with isolated lateralized overgrowth often have mosaicism, meaning the genetic change is only present in the cells of the larger limb. In these cases, a standard blood test is often negative, and doctors may recommend testing tissue from a skin biopsy or cheek swab instead.
Does my child need cancer screening if they only have isolated lateralized overgrowth?
Yes. While the risk of developing childhood tumors like Wilms tumor is lower than in classic BWS, it is still high enough that routine surveillance is strongly recommended. This typically involves regular abdominal ultrasounds until age seven or eight.
What specialists should my child see to help manage their enlarged limb?
Your child will likely be referred to a pediatric orthopedist or a physical therapist. These specialists can monitor your child's physical development, assess mobility differences, and recommend supportive interventions like shoe lifts.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Should my child's tissue test be a cheek swab, or is a skin biopsy from the larger limb recommended?
  2. 2.Based on my child's physical symptoms, do you recommend both abdominal ultrasounds and AFP blood tests for screening?
  3. 3.Can you refer us to a pediatric orthopedist or physical therapist to monitor my child's physical development and mobility?
  4. 4.Who on our care team will be responsible for managing and ordering the quarterly screening ultrasounds?
  5. 5.Should we consider testing for PROS or other overgrowth syndromes if the initial blood test is negative?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Evolution over Time of Leg Length Discrepancy in Patients with Syndromic and Isolated Lateralized Overgrowth.

    Carli D, De Pellegrin M, Franceschi L, et al.

    The Journal of pediatrics 2021; (234()):123-127 doi:10.1016/j.jpeds.2021.01.020.

    PMID: 33465347
  2. 2

    Characterization of the Beckwith-Wiedemann spectrum: Diagnosis and management.

    Duffy KA, Cielo CM, Cohen JL, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2019; (181(4)):693-708 doi:10.1002/ajmg.c.31740.

    PMID: 31469230
  3. 3

    Investigation of 11p15.5 Methylation Defects Associated with Beckwith-Wiedemann Spectrum and Embryonic Tumor Risk in Lateralized Overgrowth Patients.

    Tüysüz B, Bozlak S, Uludağ Alkaya D, et al.

    Cancers 2023; (15(6)) doi:10.3390/cancers15061872.

    PMID: 36980758
  4. 4

    Whole-exome sequencing reveals causative genetic variants for several overgrowth syndromes in molecularly negative Beckwith-Wiedemann spectrum.

    Higashimoto K, Sun F, Imagawa E, et al.

    Journal of medical genetics 2024; (61(6)):590-594 doi:10.1136/jmg-2023-109621.

    PMID: 38228391
  5. 5

    Isolated- and Beckwith-Wiedemann syndrome related- lateralised overgrowth (hemihypertrophy): Clinical and molecular correlations in 94 individuals.

    Radley JA, Connolly M, Sabir A, et al.

    Clinical genetics 2021; (100(3)):292-297 doi:10.1111/cge.13997.

    PMID: 33993487
  6. 6

    Prenatal features in Beckwith-Wiedemann syndrome and indications for prenatal testing.

    Carli D, Bertola C, Cardaropoli S, et al.

    Journal of medical genetics 2021; (58(12)):842-849 doi:10.1136/jmedgenet-2020-107311.

    PMID: 33115931
  7. 7

    Lateralized and Segmental Overgrowth in Children.

    Mussa A, Carli D, Cardaropoli S, et al.

    Cancers 2021; (13(24)) doi:10.3390/cancers13246166.

    PMID: 34944785
  8. 8

    Isolated lateralized overgrowth and the need for tumor screening: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

    Erwin AL, El Haija AA, Bennett JT, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2025; (27(10)):101480 doi:10.1016/j.gim.2025.101480.

    PMID: 40693985
  9. 9

    Isolated Lateralized Overgrowth - Phenotypic Spectrum and Molecular Alterations.

    Yadav S, Madhumita RC, Gupta N, et al.

    Indian journal of pediatrics 2025; (92(10)):1049-1055 doi:10.1007/s12098-024-05273-0.

    PMID: 39425824
  10. 10

    Performance Metrics of the Scoring System for the Diagnosis of the Beckwith-Wiedemann Spectrum (BWSp) and Its Correlation with Cancer Development.

    Luca M, Carli D, Cardaropoli S, et al.

    Cancers 2023; (15(3)) doi:10.3390/cancers15030773.

    PMID: 36765732
  11. 11

    Molecular Basis and Diagnostic Approach to Isolated and Syndromic Lateralized Overgrowth in Childhood.

    Bellucca S, Carli D, Gazzin A, et al.

    The Journal of pediatrics 2024; (274()):114177 doi:10.1016/j.jpeds.2024.114177.

    PMID: 38945442
  12. 12

    Molecular Basis of Beckwith-Wiedemann Syndrome Spectrum with Associated Tumors and Consequences for Clinical Practice.

    Eggermann T, Maher ER, Kratz CP, Prawitt D

    Cancers 2022; (14(13)) doi:10.3390/cancers14133083.

    PMID: 35804856
  13. 13

    Diffuse infantile hepatic hemangiomas in a patient with Beckwith-Wiedemann syndrome: A new association?

    Macchiaiolo M, Markowich AH, Diociaiuti A, et al.

    American journal of medical genetics. Part A 2020; (182(8)):1972-1976 doi:10.1002/ajmg.a.61718.

    PMID: 32573107

This page provides educational information about Beckwith-Wiedemann spectrum presentations. It is not a substitute for professional medical advice, diagnosis, or genetic counseling for your child.

Get notified when new evidence is published on Beckwith-Wiedemann syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.